CNCT19 Anti-CD19 Cell Therapy

CNCT19 anti-CD19 CAR-T cell therapy · Juventas Cell Therapy Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CNCT19 Anti-CD19 Cell Therapy, covering 2025-02-10 to 2025-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Exploratory Clinical Study of CNCT19 Anti CD19 Cell Therapy in the Treatment of Refractory Autoimmune Diseases [EARLY_Phase 1]

See pricing